Progress in, and future prospects for, the treatment of primary pulmonary hypertension

Heart. 2001 Dec;86(6):603-4. doi: 10.1136/heart.86.6.603.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Administration, Oral
  • Antihypertensive Agents / administration & dosage
  • Endothelins / antagonists & inhibitors
  • Epoprostenol / administration & dosage
  • Forecasting
  • Humans
  • Hypertension, Pulmonary / etiology
  • Hypertension, Pulmonary / therapy*
  • Infusions, Intravenous

Substances

  • Antihypertensive Agents
  • Endothelins
  • Epoprostenol